| TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration (NCT01134718) | Tibotec Pharmaceuticals, Ireland | 2010-06-01 |
| BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours (NCT01145885) | Boehringer Ingelheim | 2010-06-01 |
| Pounds Off Digitally (POD): The Use of Podcasting and Mobile Media to Promote Weight Loss (NCT01139255) | University of North Carolina, Chapel Hill | 2010-06-01 |
| A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer (NCT01149668) | Pharmacyclics LLC. | 2010-06-01 |
| Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer (NCT01145430) | National Cancer Institute (NCI) | 2010-06-01 |
| Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People (NCT01162889) | Pfizer | 2010-06-01 |
| Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC) (NCT01140373) | Memorial Sloan Kettering Cancer Center | 2010-06-01 |
| To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 Days (NCT01145768) | AstraZeneca | 2010-06-01 |
| Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling (NCT01154712) | BeerYaakov Mental Health Center | 2010-06-01 |
| Study of VX-985 in Subjects With Chronic Hepatitis C (NCT01144936) | Vertex Pharmaceuticals Incorporated | 2010-06-01 |
| Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet (NCT01106859) | Transcept Pharmaceuticals | 2010-06-01 |
| A Radiolabeled Mass Balance Study of [14C]-Ertugliflozin (PF04971729, MK-8835) In Healthy Male Participants (MK-8835-038) (NCT01127308) | Merck Sharp & Dohme LLC | 2010-06-01 |
| LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients (NCT01167309) | LEO Pharma | 2010-06-01 |
| Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer (NCT01218880) | Protgen Ltd | 2010-06-01 |
| First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors (NCT01323933) | Gilead Sciences | 2010-06-01 |
| Phase I, Exploratory, Single Centre, Single Oral Dose AZD9668 and Intravenous Microdose of [C14] AZD9668, Healthy Subject (NCT01161355) | AstraZeneca | 2010-06-01 |
| Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer (NCT01082068) | Sanofi | 2010-06-01 |
| Effects of California Walnuts on Vascular Function in Postmenopausal Women (NCT01072864) | University of California, Davis | 2010-06-01 |
| Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59 (NCT00912496) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-01 |
| Tolerability Study of Xerecept® in Pediatric Patients (NCT01369121) | Celtic Pharma Development Services | 2010-06-01 |
| Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants (NCT01139437) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-01 |
| Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors (NCT01148966) | University of Washington | 2010-06-01 |
| LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy Subjects (NCT01143298) | LEO Pharma | 2010-06-01 |
| Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers (NCT01156246) | AstraZeneca | 2010-06-01 |
| Reducing Aggression in Children and Adolescent on an Inpatient Unit (NCT01377948) | Gonzalez-Heydrich, Joseph, M.D. | 2010-06-01 |
| An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density (NCT01101048) | Amgen | 2010-06-01 |
| Lenalidomide in Patients With Chronic Myelomonocytic Leukemia (NCT01368757) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2010-06-01 |
| A Safety Study Of BMP-655/ACS As An Adjuvant Therapy For Treatment Of Rotator Cuff Tears (NCT01122498) | Pfizer | 2010-06-01 |
| Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults (NCT01444352) | Sanofi Pasteur, a Sanofi Company | 2010-06-01 |
| A Study of Adavosertib (MK-1775) in Combination With Topotecan/Cisplatin in Participants With Cervical Cancer (MK-1775-008) (NCT01076400) | Merck Sharp & Dohme LLC | 2010-05-31 |
| A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus (NCT01031108) | Sirtris, a GSK Company | 2010-05-28 |
| Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT) (NCT01134146) | M.D. Anderson Cancer Center | 2010-05-27 |
| 188RE-SSS Lipiodol to Treat HepatoCellular Carcinomas (NCT01126463) | Center Eugene Marquis | 2010-05-26 |
| Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery (NCT01079793) | University of Texas Southwestern Medical Center | 2010-05-26 |
| Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010) (NCT01092780) | Merck Sharp & Dohme LLC | 2010-05-26 |
| Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer (NCT01009437) | Masonic Cancer Center, University of Minnesota | 2010-05-26 |
| A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum (NCT01134601) | National Cancer Institute (NCI) | 2010-05-24 |
| Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED) (NCT01059851) | Merck Sharp & Dohme LLC | 2010-05-24 |
| GSK2018682 FTIH in Healthy Volunteers (NCT01387217) | GlaxoSmithKline | 2010-05-21 |
| Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient (NCT01424436) | GlaxoSmithKline | 2010-05-19 |
| A Drug Interaction Study of Simvastatin and Albiglutide (NCT01147692) | GlaxoSmithKline | 2010-05-19 |
| A Single Dose Study to Determine the Excretion, Balance and Metabolic Disposition of Radiolabelled GW642444. (NCT01286831) | GlaxoSmithKline | 2010-05-18 |
| Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects (NCT01299558) | GlaxoSmithKline | 2010-05-17 |
| Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer (NCT01084057) | City of Hope Medical Center | 2010-05-17 |
| Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT01130506) | National Cancer Institute (NCI) | 2010-05-17 |
| Bioequivalence Study of Montelukast 5 mg Chewable (NCT01863654) | GlaxoSmithKline | 2010-05-16 |
| Bioequivalence Study of Montelukast 10 mg Tablets (NCT01943942) | GlaxoSmithKline | 2010-05-16 |
| Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors (NCT01122199) | Shadia Jalal | 2010-05-14 |
| Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects (NCT01110031) | GlaxoSmithKline | 2010-05-13 |
| The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers (NCT01148004) | National Institutes of Health Clinical Center (CC) | 2010-05-13 |
| Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS) (NCT01143441) | National Institute of Neurological Disorders and Stroke (NINDS) | 2010-05-13 |
| Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study (NCT01101555) | GlaxoSmithKline | 2010-05-12 |
| Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT (NCT01242267) | Hackensack Meridian Health | 2010-05-11 |
| Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies (NCT01084252) | Sanofi | 2010-05-11 |
| A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors (NCT01130623) | National Cancer Institute (NCI) | 2010-05-10 |
| A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas (NCT01132911) | National Cancer Institute (NCI) | 2010-05-10 |
| W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne (NCT01132443) | Stiefel, a GSK Company | 2010-05-06 |
| A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects (NCT01114607) | GlaxoSmithKline | 2010-05-05 |
| A Study of Avonex to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers (NCT01119677) | Biogen | 2010-05-05 |
| Safety, Pharmacokinetics (PK) of AKT and MEK Combination (NCT01138085) | GlaxoSmithKline | 2010-05-04 |
| AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma (NCT01129193) | Amir Mortazavi | 2010-05-04 |
| Bioequivalence Study of Escitalopram Tablets 10 mg (NCT01745601) | GlaxoSmithKline | 2010-05-04 |
| A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese Women (NCT01101061) | Amgen | 2010-05-03 |
| A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 Diabetes (NCT01114542) | Novo Nordisk A/S | 2010-05-03 |
| Dendritic Cell Vaccination for Patients with Solid Tumors (NCT01291420) | University Hospital, Antwerp | 2010-05-03 |
| Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient (NCT01482936) | Mundipharma (China) Pharmaceutical Co. Ltd | 2010-05-01 |
| Ascorbic Acid (Vitamin C) Infusion in Human Sepsis (NCT01434121) | Virginia Commonwealth University | 2010-05-01 |
| Relative Bioavailability of Olodaterol and Fluconazole (NCT01153724) | Boehringer Ingelheim | 2010-05-01 |
| Relative Bioavailability of of Olodaterol and Ketoconazole (NCT01153711) | Boehringer Ingelheim | 2010-05-01 |
| Evaluation of the Vascutek Hybrid Graft for Use in the Replacement of the Aortic Arch and Concomitant Treatment of an Aneurysm/Dissection of the Descending Aorta in the Frozen Elephant Trunk Procedure (NCT01541410) | Vascutek Ltd. | 2010-05-01 |
| Treatment of Stress Urinary Incontinence by Injection of Autologous Muscle Fibers Into the Urethral Sphincter. (NCT01323426) | Copenhagen University Hospital at Herlev | 2010-05-01 |
| Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic Impairment (NCT01126086) | Sanofi | 2010-05-01 |
| A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives (NCT01110525) | AstraZeneca | 2010-05-01 |
| The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil (NCT01131845) | United Therapeutics | 2010-05-01 |
| A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA) (NCT01158235) | Lytix Biopharma AS | 2010-05-01 |
| Probiotics for Infectious Diarrhea in Children in South India (NCT01130792) | Christian Medical College, Vellore, India | 2010-05-01 |
| Tolerability Study of the Application of a 3M Microstructure Transdermal System (NCT01257763) | Northwestern University | 2010-05-01 |
| Safety and Pharmacology Study of BMS-866949 (NCT01124344) | Bristol-Myers Squibb | 2010-05-01 |
| Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia (NCT01132586) | National Cancer Institute (NCI) | 2010-05-01 |
| Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin (NCT01422590) | Samsung Medical Center | 2010-05-01 |
| Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia (NCT01078974) | Steven P. Treon, MD, PhD | 2010-05-01 |
| The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea (NCT01133431) | Chong Kun Dang Pharmaceutical | 2010-05-01 |
| RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma (NCT01047293) | University of Utah | 2010-05-01 |
| A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus (NCT01127321) | MedImmune LLC | 2010-05-01 |
| Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy Subjects (NCT01135446) | AstraZeneca | 2010-05-01 |
| A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes (NCT01134224) | Novo Nordisk A/S | 2010-05-01 |
| Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients (NCT01049022) | Bayer | 2010-05-01 |
| Comparison of Two Anaesthetics on Brain During Brain Tumour Surgery (NCT02229201) | University Medical Centre Ljubljana | 2010-05-01 |
| Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia (NCT01126502) | National Cancer Institute (NCI) | 2010-05-01 |
| Phase I Trial of Emulsified Isoflurane (NCT01302353) | Sichuan University | 2010-05-01 |
| JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study (NCT01105780) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-05-01 |
| Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic Impairment (NCT01134185) | Movetis | 2010-05-01 |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablet Under Fasting Conditions (NCT03318354) | Torrent Pharmaceuticals Limited | 2010-05-01 |
| Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet (ODT) And 10 Mg Amlodipine Besylate Tablets (NCT01138826) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-05-01 |
| Bioavailability, Food Effect and Safety, Tolerability of a New Oral Suspension in Comparison to the Marketed Moxifloxacin Tablet in Healthy Adults (NCT01073891) | Bayer | 2010-05-01 |
| To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients (NCT01301898) | Green Cross Corporation | 2010-05-01 |
| A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C (NCT01121731) | Digna Biotech S.L. | 2010-05-01 |
| Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039) (NCT01114490) | Merck Sharp & Dohme LLC | 2010-05-01 |
| Novel Type 2 Diabetes Mellitus Preventive Therapies (NCT02351323) | Boston Medical Center | 2010-05-01 |
| Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel (NCT01147588) | AstraZeneca | 2010-05-01 |